Reining in the high cost of prescription drugs has been a major aim of the Trump administration, marked most notably by the president's 2018 "Blueprint…

Taking steps in advance to avoid these risks will not eliminate them, but it better position employers to defend future litigation.

Legislation on drug price reform may be slowed, but it's important to understand the potential impact of the bills on the table.

"Just during the COVID-19 pandemic time, we've pushed out almost $124 million," says Florida Chief Financial Officer Jimmy Patronis.